Welcome to our dedicated page for Waystar Holding news (Ticker: WAY), a resource for investors and traders seeking the latest updates and insights on Waystar Holding stock.
Waystar Holding Corp. (Nasdaq: WAY) is a healthcare payment software company whose news flow centers on technology innovation, financial performance, and capital markets activity. As a provider of mission-critical, cloud-native software for healthcare payments, Waystar regularly issues updates about its AI capabilities, platform enhancements, and the impact of its solutions on revenue cycle operations for providers.
Readers of this news page can expect coverage of announcements related to Waystar AltitudeAI™, agentic intelligence, and the company’s broader vision for an autonomous revenue cycle. Recent communications have highlighted how Waystar’s AI-powered platform is used to prevent claim denials, accelerate denial appeals, improve reimbursement recovery, and reduce administrative workload across clinical documentation and billing workflows.
Waystar also reports quarterly and annual financial results, which are typically accompanied by earnings press releases and Form 8-K filings. These updates may include discussions of revenue trends, margins, key operating metrics, and guidance, as well as commentary from management on business performance. In addition, the company announces participation in investor conferences and presentations at major healthcare and technology events, reflecting its engagement with the investment community.
Corporate development and strategic transactions are another important theme in Waystar’s news. The company has announced the acquisition and integration of Iodine Software, describing how the combination of large clinical and financial datasets enhances its AI platform and expands its total addressable market. Index-related news, such as Waystar’s inclusion in the S&P SmallCap 600® Index, also appears in its releases.
For investors, analysts, and healthcare professionals, this news page provides a centralized view of Waystar’s product innovations, AI initiatives, financial disclosures, capital structure developments, and strategic milestones. Regular visits can help readers follow how the company’s software platform and data assets are evolving within the U.S. healthcare payment landscape.
Waystar Holding Corp. (Nasdaq: WAY) has announced a proposed underwritten public offering of 18,000,000 shares of its common stock. The offering is being made by certain investment funds of EQT AB, Canada Pension Plan Investment Board, and Bain Capital, LP (the Selling Stockholders). The underwriters will have a 30-day option to purchase up to 2,700,000 additional shares.
The offering is being led by J.P. Morgan, Goldman Sachs & Co. , and Barclays as joint lead book-running managers. Importantly, Waystar will not receive any proceeds from the sale of shares in this offering. A registration statement on Form S-1 has been filed with the SEC but has not yet become effective.
Waystar Holding Corp. (WAY) reported strong Q4 and fiscal year 2024 results, with annual revenue reaching $944M, up 19% year-over-year. Q4 revenue grew 18% to $244.1M, with net income of $19.1M and adjusted EBITDA of $100.2M.
The company demonstrated solid performance metrics, including a 110% net revenue retention rate and 1,203 clients contributing over $100,000 in LTM revenue, up 15% YoY. Subscription revenue grew 18% to $121.6M, while volume-based revenue increased 19% to $121.2M.
For fiscal year 2025, Waystar projects revenue between $1.0-1.016B and adjusted EBITDA between $399-407M. The company expects non-GAAP net income of $237-243M and diluted non-GAAP EPS of $1.29-1.32.
Waystar Holding Corp. (Nasdaq: WAY) has been recognized as the leading AI-powered software platform by Black Book Market Research™, securing top rankings in eight categories. The recognition comes from an independent survey of over 1,300 healthcare executives evaluating 80 vendors' AI-powered revenue cycle management solutions.
The company dominated in key areas including claim accuracy, operational efficiency, reduction in administrative burden, and patient engagement. Notably, Waystar outperformed competitors, with no other vendor securing more than one top ranking out of the 18 AI categories.
In January, Waystar launched AltitudeAI™, featuring AltitudeCreate™, a pioneering generative AI capability for appealing denied claims. The platform excels in claim management, showing significant improvements in claim rejection rates, clean claim submissions, and reimbursement turnaround time. Additionally, Waystar leads in patient collections and engagement, offering AI-driven tools that enhance payment collection rates while maintaining patient satisfaction.
Waystar Holding Corp. (Nasdaq: WAY) has secured top rankings in multiple 2025 Best in KLAS categories, specifically in Claims Management & Clearinghouse and Patient Access solutions. The recognition is based on independent client feedback and highlights Waystar's excellence in healthcare payment software.
The company's AI-powered platform, driven by Waystar AltitudeAI™, helps healthcare providers optimize revenue cycle workflows by integrating front-end patient access with back-end claims management. In 2024, Waystar demonstrated industry leadership by successfully implementing its Accelerated Implementation Program, which helped onboard over 30,000 providers during a nationwide cyber incident affecting claims processing.
The company's recent achievements include recognition from Forbes' Most Trusted Companies in America, Fortune's Best Workplaces in Health Care, and multiple Gold Stevie® Awards for cloud-based software and AI leadership. This marks over a dozen consecutive years of Waystar being named Best in KLAS.
Waystar Holding Corp. (Nasdaq: WAY), a healthcare payment software provider, has scheduled its Q4 and fiscal year 2024 financial results announcement for February 18, 2025, before market open. The company will host a conference call at 8:30 a.m. Eastern Time on the same day to discuss the results. A live audio webcast will be available on Waystar's investor relations website, with an archived version accessible for those unable to attend the live event.
Waystar (Nasdaq: WAY) has launched Waystar AltitudeAI™, featuring AltitudeCreate™, a groundbreaking generative AI technology designed to automate the appeal process for denied healthcare claims. The innovation aims to help providers recover substantial portions of payments from over 450 million annually denied claims.
The initiative addresses significant challenges in healthcare administration, where $350 billion is lost annually to administrative waste, and hospitals spend $20 billion yearly attempting to overturn denied claims. More than half of denied claims are ultimately overturned, but the process is traditionally time-consuming and error-prone.
Waystar's platform processes over five billion annual transactions for approximately 50% of patients nationwide. The company's AI capabilities are now unified under the Waystar AltitudeAI™ brand, focusing on improving healthcare payment efficiency and accuracy.
Waystar Holding Corp. (Nasdaq: WAY), a leading healthcare payment software provider, has announced its participation in the upcoming 43rd Annual J.P. Morgan Healthcare Conference. CEO Matt Hawkins will deliver a presentation on Monday, January 13, 2025, at 11:15 a.m. PT.
The company will provide real-time access to the presentation through a live webcast on their Investor Relations website. For those unable to attend or watch live, a recording will be made available on the same platform following the event. Interested parties can access the webcast at https://investors.waystar.com/news-events/events.
Waystar Holding Corp. (WAY) announced amendments to its first lien credit agreement, enhancing its financial flexibility and reducing borrowing costs. The company's term loan interest rate has been reduced to adjusted SOFR +2.25% from SOFR +2.75%. Additionally, the revolving credit facility has been expanded to $400 million from $342.5 million, with its interest rate lowered to adjusted SOFR +1.75% from SOFR +2.25%.
These changes follow Waystar's IPO on June 7, 2024, where proceeds were used to reduce debt, and a previous loan repricing on June 27, 2024.
Waystar Holding Corp. (Nasdaq: WAY) has been named one of Forbes' Most Trusted Companies in America, placing among the top 15% of 2,000 evaluated public companies. The recognition was based on four key categories: customer trust, employee trust, investor trust, and media sentiment.
The healthcare payment software provider has demonstrated strong performance in client satisfaction, with 98% of clients rating Waystar's trust delivery as very well or extremely well. The company ranked #1 versus competitors in client satisfaction and product innovation.
In 2024, Waystar has received multiple accolades including Fortune's Best Workplaces in Health Care, the Healthcare Payments Innovation Award from MedTech Breakthrough, and multiple Gold Stevie® Awards for its cloud-based platform and AI leadership. The company serves over 1 million providers through its AI-driven automation and cloud-based software platform.
Waystar Holding Corp (Nasdaq: WAY), a healthcare payment software provider, has announced its participation in two upcoming investor conferences. CEO Matt Hawkins will present at the Evercore ISI HealthCONx Conference on December 4, 2024, at 1:20 p.m. ET, and the Barclays 22nd Annual Global Technology Conference on December 12, 2024, at 11:00 a.m. PT. Both presentations will be available via live webcasts on Waystar's Investor Relations website, with recordings accessible afterward.